Article
The structure of the CYLD USP domain explains its specificity for Lys63-linked polyubiquitin and reveals a B box module.
Molecular cell - 29 Feb 2008
Komander David, Lord Christopher J, Scheel Hartmut, Swift Sally, Hofmann Kay, Ashworth Alan, Barford David
Abstract excerpt
The tumor suppressor CYLD antagonizes NF-kappaB and JNK signaling by disassembly of Lys63-linked ubiquitin chains synthesized in response to cytokine stimulation. Here we describe the crystal structure of the CYLD USP domain, revealing a distinctive architecture that provides molecular insights into its specificity toward Lys63-linked polyubiquitin. We identify regions of the USP domain responsible for this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
